ChromaDex (CDXC) Reports Q2 EPS of $0.00

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to ChromaDex (CDXC) Reports Q2 EPS of $0.00

ChromaDex Reports Record Revenue as Ingredients Sales Climb 83% Compared to Previous Year Period

August 11, 2016 4:10 PM EDT

IRVINE, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today record revenue for the second quarter ended July 2, 2016. 

Results of operations for the three months ended July 2, 2016

For the three months ended July 2, 2016 (Q2 2016), ChromaDex reported record net sales of $8.8 million, an increase of 45% as compared to $6.1 million for the three months ended July 4, 2015 (Q2 2015).  This increase was... More